Viatris Inc
NASDAQ:VTRS
Viatris Inc
Cash from Investing Activities
Viatris Inc
Cash from Investing Activities Peer Comparison
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Viatris Inc
NASDAQ:VTRS
|
Cash from Investing Activities
-$764.1m
|
CAGR 3-Years
-36%
|
CAGR 5-Years
9%
|
CAGR 10-Years
9%
|
|
Johnson & Johnson
NYSE:JNJ
|
Cash from Investing Activities
$878m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Cash from Investing Activities
-$2.3B
|
CAGR 3-Years
40%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
-15%
|
|
Pfizer Inc
NYSE:PFE
|
Cash from Investing Activities
-$32.3B
|
CAGR 3-Years
-96%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-12%
|
|
Merck & Co Inc
NYSE:MRK
|
Cash from Investing Activities
-$14.1B
|
CAGR 3-Years
-14%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-16%
|
|
Eli Lilly and Co
NYSE:LLY
|
Cash from Investing Activities
-$7.2B
|
CAGR 3-Years
-47%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-13%
|
See Also
What is Viatris Inc's Cash from Investing Activities?
Cash from Investing Activities
-764.1m
USD
Based on the financial report for Dec 31, 2023, Viatris Inc's Cash from Investing Activities amounts to -764.1m USD.
What is Viatris Inc's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 10Y
9%
The average annual Cash from Investing Activities growth rates for Viatris Inc have been -36% over the past three years , 9% over the past five years , and 9% over the past ten years .